In this month’s Legal Eagle column, we delve into cases involving informed consent.
San Francisco - Two new dermal fillers approved for use without a pre-treatment skin test will enable dermatologists to offer patients same-day collagen replacement therapy.
Slathering the body with the same skin-care products designed for the face is a bad idea, experts say.
According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.
A grant from the Melanoma Research Foundation powers the initial stages of the project.
National report - Skin disease is one of the main reasons for consultation in travelers returning from the tropics, according to Eric Caumes, M.D., professor of infectious diseases and dermatologist in the department of infectious and tropical diseases at Hospital Piti?-Salp?tri?re in Paris.
Bronchial hyperreactivity associated with propranolol treatment for infantile hemangiomas may be due to age and low body weight, study shows.
The patient must be psychologically prepared for the clinical picture of the desquamation that results from the peel.
The current financial crisis has left many Americans with less wealth than they had just a year ago. Home and stock market investments are likely worth a lot less ? and it may be years until the values of these assets return to previous levels. Investment advisers Carole C. Foos, C.P.A., and David B. Mandell, J.D., M.B.A., offer a strategy with two simple steps to help you start now to make up for your losses.
The acne medication Clindagel (clindamycin phosphate 1 percent) topical gel is now owned by Onset Dermatologics, according to a news release.
Up to 30 percent of patients with psoriasis do not seek medical care for their skin condition, patient surveys show.
The Food and Drug Administration has approved Varithena (polidocanol injectable foam, BTG International) for the treatment of varicose veins.
While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.
An expert in dermatology shares her thoughts on the role and efficacy of hydrophobically-modified polymers and green cleansing technologies comparing them to more traditional methods at AAD.
Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.
I thoroughly enjoyed the lead article about “antimicrobial stewardship” in the October edition of Dermatology Times (“Antimicrobial stewardship: How dermatologists can be part of the solution, Vol. 34, No. 10). It succinctly and effectively detailed that for healthcare providers in general and dermatologists in specific, it is our duty to utilize antimicrobials appropriately.
What will the aesthetic medicine look like in 2021? Dr. Suneel Chilukuri offers his perspective on how the pandemic will influence the practice in the New Year.
An exploration of the feasibility of using laser technology to detect changes in microvasculature during the acne lesion healing progress and to introduce a microvasculature-based biomarker in evaluating the treatment and grading of acne.
The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.
A panel discussion on the increasing trend of total body skin lightening ― and ethical and health concerns associated with skin lightening ― was this year's most discussesd and controversial topic.
In April we reviewed the first five tips to help boost your resilience and well being in 2018. Below are the final five in the second part of this two-part article.
Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.
Marketing expert Justin Knott explains how to grow your Instagram following as part of a successful digital practice marketing strategy.
WE medical trip to India ends in eye-opening lessons learned.
Pennsylvania Dermatology Partners tells its story of technological support and success.
Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.
Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
In recognition of the first anniversary of our Innovation column, Drs. Steve Xu and William Ju reflect on the range of topics covered throughout the year and highlight what's to come.
Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.